More on ELTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+28.3% Growth)
- Ratings (6.7 Score)

Upcoming Events

- Earnings (11/13/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Elicio Therapeutics (NQ:ELTX)
Delayed: 1.56 -0.22 (12.36%)
Prev. Close $1.78  
Open$1.81 
52 Wk High$ 
52 Wk Low$ 
Day High$1.85 
Day Low$1.55 
P/E N/A  
EPS$ 
Volume333,931 

Friends, Peers and Foes (?): AEMD, AZN HURA (more...)

Oct 9, 2026 04:06 PM Form DEF 14A Elicio Therapeutics, For: Dec 31
Sep 24, 2026 08:33 AM Elicio Therapeutics (ELTX) PT Lowered to $8 at B.Riley
Sep 24, 2026 08:02 AM Elicio to present Phase 2 pancreatic cancer data at ESMO 2026
Sep 24, 2026 08:00 AM Elicio Therapeutics Announces Late-Breaking Phase 2 AMPLIFY-7P Data Selected for Proffered Paper Oral Presentation at ESMO Congress 2026
Sep 14, 2026 04:04 PM Form 8-K Elicio Therapeutics, For: Sep 14
Aug 31, 2026 08:00 AM Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference
Aug 24, 2026 08:00 AM Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
Aug 18, 2026 06:42 AM H.C. Wainwright Reiterates Buy Rating on Elicio Therapeutics (ELTX)
Aug 13, 2026 04:10 PM Form 10-Q Elicio Therapeutics, For: Jun 30
Aug 13, 2026 04:09 PM Form 8-K Elicio Therapeutics, For: Aug 13
View All Articles

Entities mentioned with ELTX

View All Entities